{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:11:02Z","timestamp":1793387462503,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pnpbp.2019.109735","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T19:53:57Z","timestamp":1566244437000},"page":"109735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"96","author":[{"given":"Anees","family":"Bahji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Hawken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4103\/0253-7176.122222","article-title":"Assessment of cognitive behavioral therapy on quality of life of patients with Chronic War-related Post-traumatic stress disorder","volume":"35","author":"Ahmadizadeh","year":"2013","journal-title":"Indian J. Psychol. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109735_bb0010","first-page":"32","article-title":"Pharmacotherapy for post-traumatic stress disorder in combat Veterans","volume":"37","author":"Alexander","year":"2012","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.pnpbp.2019.109735_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th Edition","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0025","series-title":"Clinical Practice Guidelines for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults [Internet]","author":"American Psychiatric Association","year":"2017"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109735_bb0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/02791072.2015.1094156","article-title":"The Psychopharmacology of +\/-3,4 Methylenedioxymethamphetamine and its role in the treatment of Posttraumatic Stress Disorder. [Review]","volume":"47","author":"Amoroso","year":"2015","journal-title":"J. Psychoactive Drugs"},{"issue":"7","key":"10.1016\/j.pnpbp.2019.109735_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/0269881116642542","article-title":"Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: a preliminary meta-analysis and comparison to prolonged exposure therapy. [Review]","volume":"30","author":"Amoroso","year":"2016","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109735_bb0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1601-183X.2012.00801.x","article-title":"Fear extinction and BDNF: translating animal models of PTSD to the clinic","volume":"11","author":"Andero","year":"2012","journal-title":"Genes Brain Behav."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychores.2015.04.006","article-title":"Prevention of posttraumatic stress disorder with propranolol: a meta-analytic review","volume":"79","author":"Argolo","year":"2015","journal-title":"J. Psychosom. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.9740\/mhc.2017.03.088","article-title":"D-cycloserine in the treatment of posttraumatic stress disorder","volume":"7","author":"Baker","year":"2017","journal-title":"Ment Health Clin."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2008.04.009","article-title":"Oxytocin shapes the neural circuitry of trust and trust adaptation in humans","volume":"58","author":"Baumgartner","year":"2008","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109735_bb0060","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/0269881116663120","article-title":"The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?","volume":"30","author":"Bershad","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109735_bb0065","first-page":"75","article-title":"The development of a Clinician-administered PTSD Scale","volume":"8","author":"Blake","year":"1995","journal-title":"J. Trauma. Stress"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109735_bb0070","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005053-199106000-00012","article-title":"Changes in plasma norepinephrine to combat-related stimuli among Vietnam veterans with posttraumatic stress disorder","volume":"179","author":"Blanchard","year":"1991","journal-title":"J. Nerv. Ment. Dis."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109735_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/02791072.2008.10400637","article-title":"MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder","volume":"40","author":"Bouso","year":"2008","journal-title":"J. Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109735_bb0080","first-page":"39","article-title":"Noradrenergic mechanisms in stress and anxiety: II","volume":"23","author":"Bremner","year":"1996","journal-title":"Clin. Stud. Synap. N Y N."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archpsyc.1997.01830160092012","article-title":"Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse","volume":"54","author":"Bremner","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109735_bb0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1176\/appi.ajp.2017.17050481","article-title":"Reduction of PTSD Symptoms With Pre-Reactivation propranolol therapy: a randomized controlled trial","volume":"175","author":"Brunet","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0095","first-page":"417","article-title":"Taking psychedelics seriously","volume":"21","author":"Byock","year":"2018","journal-title":"J. Pain Symptom Manage."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109735_bb0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0706743717723825","article-title":"Mental disorder symptoms among public safety personnel in Canada","volume":"63","author":"Carleton","year":"2018","journal-title":"Can J. Psychiatry Rev. Can Psychiatr."},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109735_bb0105","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/0269881113495119","article-title":"MDMA assisted psychotherapy found to have a large effect for chronic post-traumatic stress disorder","volume":"27","author":"Chabrol","year":"2013","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109735_bb0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0006-3223(02)01505-6","article-title":"Cerebral function in posttraumatic stress disorder during verbal working memory updating: a positron emission tomography study","volume":"53","author":"Clark","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0115","series-title":"Reviewer Manager (RevMan) [Internet]","author":"Cochrane Systematic Reviews","year":"2014"},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109735_bb0120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cpr.2009.09.001","article-title":"Emerging treatments for PTSD","volume":"29","author":"Cukor","year":"2009","journal-title":"Clin. Psychol. Rev."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109735_bb0125","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/npp.2013.317","article-title":"D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial","volume":"39","author":"Difede","year":"2014","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2019.109735_bb0130","series-title":"Course, and Prevalence of PTSD [Internet]","author":"Disorder C on the A of OE in the T of PS, Populations B on the H of S, Medicine I of. Diagnosis","year":"2014"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/02791072.2002.10399952","article-title":"A clinical plan for MDMA (Ecstasy) in the treatment of Posttraumatic Stress Disorder (PTSD): partnering with the FDA","volume":"34","author":"Doblin","year":"2002","journal-title":"J. Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109735_bb0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biopsych.2014.10.015","article-title":"Oxytocin facilitates the extinction of conditioned fear in humans","volume":"78","author":"Eckstein","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"Pt A","key":"10.1016\/j.pnpbp.2019.109735_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pnpbp.2018.03.003","article-title":"MDMA-assisted psychotherapy for PTSD: are memory reconsolidation and fear extinction underlying mechanisms?","volume":"84","author":"Feduccia","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fphar.2016.00035","article-title":"The therapeutic potentials of Ayahuasca: possible effects against various Diseases of Civilization","volume":"7","author":"Frecska","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/A:1011112917797","article-title":"Working memory in posttraumatic stress disorder--an event-related potential study","volume":"14","author":"Galletly","year":"2001","journal-title":"J. Trauma. Stress"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109735_bb0160","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1359-1789(03)00045-4","article-title":"Psychological sequelae of combat violence: a review of the impact of PTSD on the veteran\u2019s family and possible interventions","volume":"9","author":"Galovski","year":"2004","journal-title":"Aggress. Violent Behav."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109735_bb0165","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/appi.ajp.158.8.1227","article-title":"CSF norepinephrine concentrations in posttraumatic stress disorder","volume":"158","author":"Geracioti","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-6-6","article-title":"Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs","volume":"6","author":"Han","year":"2006","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.109735_bb0175","article-title":"Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)","volume":"7","author":"Hetrick","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2019.109735_bb0180","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0185","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.2011.78","article-title":"The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (\u201cecstasy\u201d) in humans","volume":"90","author":"Hysek","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109735_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036476","article-title":"Duloxetine inhibits effects of MDMA (\u201cecstasy\u201d) in vitro and in humans in a randomized placebo-controlled laboratory study","volume":"7","author":"Hysek","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0195","article-title":"Hypothesis: the Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process","volume":"5","author":"Inserra","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109735_bb0200","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"49","key":"10.1016\/j.pnpbp.2019.109735_bb0205","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1523\/JNEUROSCI.3984-05.2005","article-title":"Oxytocin modulates neural circuitry for social cognition and fear in humans","volume":"25","author":"Kirsch","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"70","key":"10.1016\/j.pnpbp.2019.109735_bb0210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pnpbp.2016.01.015","article-title":"Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future","volume":"03","author":"Koek","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109735_bb0215","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/npp.2010.123","article-title":"Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder","volume":"35","author":"Labuschagne","year":"2010","journal-title":"Neuropsychopharmacol Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.109735_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0225","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1176\/appi.ajp.2011.10121780","article-title":"Resting amygdala and medial prefrontal metabolism predicts functional activation of the fear extinction circuit","volume":"169","author":"Linnman","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109735_bb0230","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1176\/appi.ajp.2015.14111460","article-title":"Association of resting metabolism in the fear neural network with extinction recall activations and clinical measures in trauma-exposed individuals","volume":"173","author":"Marin","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0235","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4088\/JCP.15r10334","article-title":"A Meta-analysis of D-Cycloserine in Exposure-Based Treatment: moderators of treatment efficacy, response, and diagnostic remission","volume":"78","author":"McGuire","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/SAR.S37258","article-title":"3,4-methylenedioxymethamphetamine (MDMA): current perspectives","volume":"4","author":"Meyer","year":"2013","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.pnpbp.2019.109735_bb0245","series-title":"A Manual for MDMA-Assisted Psychotherapy in the Treatment of Post-traumatic Stress Disorder","author":"Mithoefer","year":"2016"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0250","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0269881110378371","volume":"25","author":"Mithoefer","year":"2011","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109735_bb0255","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0269881112456611","article-title":"Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study","volume":"27","author":"Mithoefer","year":"2013","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109735_bb0260","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S2215-0366(15)00576-3","article-title":"Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA","volume":"3","author":"Mithoefer","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0265","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"30","author":"Mithoefer","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109735_bb0270","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2018.11.930","article-title":"S.08.06 MDMA-assisted psychotherapy for PTSD: a promising novel experimental treatment moving into phase 3 trials with FDA breakthrough therapy designation","volume":"29","author":"Mithoefer","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"329","key":"10.1016\/j.pnpbp.2019.109735_bb0280","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbr.2017.04.052","article-title":"The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization","volume":"30","author":"Mouri","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"7754","key":"10.1016\/j.pnpbp.2019.109735_bb0285","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-019-1075-9","article-title":"Oxytocin-dependent reopening of a social reward learning critical period with MDMA","volume":"569","author":"Nardou","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109735_bb0290","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0295","series-title":"Operational Stress Injury: The Impact on Family Mental Health and Wellbeing: A Report to Veteran Affairs Canada","author":"Norris","year":"2015"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0300","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000080952","article-title":"Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder","volume":"50","author":"O\u2019Donnell","year":"2004","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109735_bb0305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0269881112464827","article-title":"A randomized, controlled pilot study of MDMA (+\/- 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)","volume":"27","author":"Oehen","year":"2013","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0310","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.2018.19290","article-title":"Management of Posttraumatic stress disorder","volume":"321","author":"Ostacher","year":"2019","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109735_bb0315","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/0269881118806297","article-title":"3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial","volume":"32","author":"Ot\u2019alora","year":"2018","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0320","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00213-007-0703-5","article-title":"The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine) : an evidence-based review","volume":"191","author":"Parrott","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0325","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hup.2318","article-title":"Human psychobiology of MDMA or \u201cEcstasy\u201d: an overview of 25 years of empirical research","volume":"28","author":"Parrott","year":"2013","journal-title":"Hum. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0330","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hup.2390","article-title":"MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014)","volume":"29","author":"Parrott","year":"2014","journal-title":"Hum. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109735_bb0335","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cpr.2010.04.007","article-title":"A meta-analytic review of prolonged exposure for posttraumatic stress disorder","volume":"30","author":"Powers","year":"2010","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.pnpbp.2019.109735_bb0340","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ynstr.2014.11.004","article-title":"The influence of acute stress on the regulation of conditioned fear","volume":"1","author":"Raio","year":"2014","journal-title":"Neurobiol. Stress."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0345","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.biopsych.2006.06.004","article-title":"Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future","volume":"60","author":"Rauch","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109735_bb0350","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ijnurstu.2009.01.002","article-title":"The impact of PTSD on veterans\u2019 family relationships: an interpretative phenomenological inquiry","volume":"46","author":"Ray","year":"2009","journal-title":"Int. J. Nurs. Stud."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109735_bb0355","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamapsychiatry.2016.2729","article-title":"Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for Posttraumatic stress disorder: a randomized clinical trial","volume":"74","author":"Resick","year":"2017","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109735_bb0360","first-page":"10","article-title":"Turn on and tune in to evidence-based psychedelic research","volume":"2","author":"Sessa","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0365","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neulet.2016.07.004","article-title":"MDMA and PTSD treatment: \u201cPTSD: from novel pathophysiology to innovative therapeutics\u201d","volume":"649","author":"Sessa","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109735_bb0370","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s13311-017-0531-1","article-title":"Why psychiatry needs 3,4-Methylenedioxymethamphetamine: a child Psychiatrist\u2019s Perspective. [Review]","volume":"14","author":"Sessa","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109735_bb0375","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1024444410595","article-title":"Effects of psychotherapeutic treatments for PTSD: a meta-analysis of controlled clinical trials","volume":"11","author":"Sherman","year":"1998","journal-title":"J. Trauma. Stress"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109735_bb0380","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0897190007300735","article-title":"Sleep disturbances in patients with psychiatric illnesses","volume":"19","author":"Singh","year":"2006","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.pnpbp.2019.109735_bb0385","first-page":"18(4)","article-title":"Efficacy of Prazosin in Posttraumatic stress disorder: a systematic review and meta-analysis","volume":"28","author":"Singh","year":"2016","journal-title":"Prim Care Comp. CNS Disord."},{"key":"10.1016\/j.pnpbp.2019.109735_bb0390","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14196\/mjiri.31.60","article-title":"The effect of 3,4- methylenedioxymethamphetamine on expression of neurotrophic factors in hippocampus of male rats","volume":"31","author":"Soleimani Asl","year":"2017","journal-title":"Med. J. Islam Repub. Iran"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0395","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/archpsyc.1993.01820160036003","article-title":"Abnormal noradrenergic function in posttraumatic stress disorder","volume":"50","author":"Southwick","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109735_bb0400","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archpsyc.1997.01830200083012","article-title":"Noradrenergic and serotonergic function in posttraumatic stress disorder","volume":"54","author":"Southwick","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0405","first-page":"242","article-title":"Neurotransmitter alterations in PTSD: catecholamines and serotonin","volume":"4","author":"Southwick","year":"1999","journal-title":"Semin. Clin. Neuropsychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109735_bb0410","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0006-3223(99)00219-X","article-title":"Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder","volume":"46","author":"Southwick","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109735_bb0415","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.2015.8370","article-title":"Psychotherapy for Military-Related PTSD: a review of randomized clinical trials","volume":"314","author":"Steenkamp","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.pnpbp.2019.109735_bb0420","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0006-3223(02)01414-2","article-title":"Neuropsychological function in female victims of intimate partner violence with and without posttraumatic stress disorder","volume":"52","author":"Stein","year":"2002","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0425","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0193-953X(18)30122-9","article-title":"Pharmacotherapy for post-traumatic stress disorder","volume":"17","author":"Sutherland","year":"1994","journal-title":"Psychiatr. Clin. North Am."},{"issue":"16","key":"10.1016\/j.pnpbp.2019.109735_bb0430","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12888-016-0979-2","article-title":"The relative efficacy of bona fide psychotherapies for post-traumatic stress disorder: a meta-analytical evaluation of randomized controlled trials","volume":"26","author":"Tran","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0435","first-page":"77","article-title":"A literature review: the efficacy of MDMA-Assisted PTSD Psychotherapy","volume":"2","author":"Tsai","year":"2017","journal-title":"Simon Fraser Univ. Sci. Undergrad. Res. J."},{"issue":"11 Suppl","key":"10.1016\/j.pnpbp.2019.109735_bb0440","first-page":"3","article-title":"Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder","volume":"161","author":"Ursano","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2019.109735_bb0445","doi-asserted-by":"crossref","first-page":"A41","DOI":"10.1186\/1471-2210-9-S2-A41","article-title":"A single neurotoxic dose of MDMA decreases BDNF expression in the frontoparietal cortex but not in the hippocampus","volume":"9","author":"Vas","year":"2009","journal-title":"BMC Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109735_bb0450","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1037\/0894-4105.16.1.5","article-title":"Attention, learning, and memory performances and intellectual resources in Vietnam veterans: PTSD and no disorder comparisons","volume":"16","author":"Vasterling","year":"2002","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109735_bb0455","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","article-title":"MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment","volume":"189","author":"Verrico","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0460","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/0269881107083639","article-title":"MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine\/norepinephrine transport inhibitor","volume":"22","author":"Verrico","year":"2008","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0465","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0079-6123(08)00418-4","article-title":"Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response","volume":"170","author":"Viviani","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.109735_bb0470","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1177\/1060028014532236","article-title":"3,4-Methylenedioxymethamphetamine\u2019s (MDMA\u2019s) Impact on Posttraumatic stress disorder","volume":"48","author":"White","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.pnpbp.2019.109735_bb0475","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nlm.2016.09.016","article-title":"Deficient fear extinction memory in posttraumatic stress disorder","volume":"136","author":"Wicking","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109735_bb0480","doi-asserted-by":"crossref","first-page":"26","DOI":"10.35502\/jcswb.6","article-title":"On the economics of post-traumatic stress disorder among first responders in Canada","volume":"1","author":"Wilson","year":"2016","journal-title":"J. Community Saf. Well-Being"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109735_bb0485","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1176\/ajp.149.3.333","article-title":"Exposure to atrocities and severity of chronic posttraumatic stress disorder in Vietnam combat veterans","volume":"149","author":"Yehuda","year":"1992","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109735_bb0490","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0006-3223(98)00276-5","article-title":"Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event","volume":"44","author":"Yehuda","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109735_bb0495","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.138","article-title":"3,4-Methylenedioxymethamphetamine facilitates fear extinction learning","volume":"5","author":"Young","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"19","key":"10.1016\/j.pnpbp.2019.109735_bb0500","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1007\/s00213-017-4684-8","article-title":"Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)","volume":"234","author":"Young","year":"2017","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619301484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619301484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:47:37Z","timestamp":1759520857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584619301484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":100,"alternative-id":["S0278584619301484"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109735","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109735"}}